Aethlon Medical, Inc. (AEMD) Shareholder/Analyst Call Prepared Remarks TranscriptSeeking Alpha · Oct 1, 2026
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)GuruFocus · Sep 18, 2026
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Aethlon Medical, Inc. (NASDAQ: AEMD)PRNewsWire · Sep 18, 2026
Aethlon Stock Pulls Back: What's Going On?Benzinga · Sep 18, 2026
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ruger & Company, Inc. (NYSE – RGR), Atkore, Inc. (NYSE – ATKR), Centerspace (NYSE – CSR), Aethlon Medical, Inc. (Nasdaq – AEMD)GlobeNewsWire · Sep 17, 2026
Aethlon Medical Pivots to Biotechnology with All-Stock MergerBenzinga · Sep 17, 2026Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 13, 2026 | -$3.92 | -$4.02 | Miss |
| Jun 10, 2026 | -$12.30 | $20.40 | Beat |
| Feb 12, 2026 | -$10.05 | -$12.25 | Miss |
| Nov 12, 2025 | -$8.50 | -$18.70 | Miss |
| Aug 13, 2025 | -$34.00 | -$42.50 | Miss |
| Jun 26, 2025 | -$4.90 | -$161.00 | Miss |